Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes

It has been debated for several years as to whether the antidiabetic drug pioglitazone increases the risk for bladder cancer. A series of recent large population studies yielded conflicting results. To investigate why the observational studies yielded conflicting results, we conducted stratified ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Hua, Zheng, Yi, Wang, Yuren, Zhang, Rui, Ruan, Xiongzhong, Yang, Gangyi, Liu, Zhenqi, Zheng, Hongting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694000/
https://www.ncbi.nlm.nih.gov/pubmed/29150684
http://dx.doi.org/10.1038/s41598-017-16074-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694000/
https://www.ncbi.nlm.nih.gov/pubmed/29150684
http://dx.doi.org/10.1038/s41598-017-16074-1

Ejemplares similares